Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma

NCT02426281 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: nab-paclitaxel
DRUG: gemcitabine

Sponsor

Samsung Medical Center